Spurstone Advisory Services »

Xeris Pharmaceuticals shares owned by Spurstone Advisory Services

Quarter-by-quarter ownership of Xeris Pharmaceuticals (XERS) shares owned by Spurstone Advisory Services from 13F filings

Historical chart of Spurstone Advisory Services investment in Xeris Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Xeris Pharmaceuticals held by Spurstone Advisory Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xeris Pharmaceuticals by Spurstone Advisory Services

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.6k 200 8.14
2025-06-30 $934 200 4.67
2025-03-31 $1.1k 200 5.49

More positions owned by Spurstone Advisory Services

Apple Common / Ordinary Stock (AAPL)
RTX Corp Common / Ordinary Stock (RTX)
HCA Healthcare Common / Ordinary Stock (HCA)
SSgA Funds Management Exchange Traded Fund (SPY)
Exxon Mobil Corp Common / Ordinary Stock (XOM)
Chevron Corp Common / Ordinary Stock (CVX)
Utd Parcel Serv Common / Ordinary Stock (UPS)
Palo Alto Networks Common / Ordinary Stock (PANW)
Crowdstrike Holdings Common / Ordinary Stock (CRWD)
Fortinet Common / Ordinary Stock (FTNT)
Pfizer Common / Ordinary Stock (PFE)
Johnson & Johnson Common / Ordinary Stock (JNJ)
Travelers Common / Ordinary Stock (TRV)
Salesforce Common / Ordinary Stock (CRM)
Phillips 66 Common / Ordinary Stock (PSX)

View all positions for Spurstone Advisory Services

Top funds holding Xeris Pharmaceuticals

BlackRock
Vanguard Group
D. E. Shaw & Co
Geode Capital Management
State Street Corporation
Qube Research & Technologies
Nuveen
Driehaus Capital Management
Rosalind Advisors
Goldman Sachs Group
Parkman Healthcare Partners
UBS Group
Connor, Clark & Lunn Investment Management
Renaissance Technologies
Two Sigma Investments

View all funds holding Xeris Pharmaceuticals